JenaValve announces strategic investment and licensing agreement with Peijia Medical

JenaValve Technology announced a strategic investment and exclusive technology licensing agreement with Peijia Medical Limited, granting Peijia exclusive rights to develop and commercialize JenaValve's Trilogy TAVR systems in Greater China, in exchange for cash, equity, and milestone payments.

“JenaValve Technology, Inc. today announced a strategic investment and exclusive technology licensing agreement with Peijia Medical Limited (HKEX: 9996) in China.”jenavalve.com

• 1 source
• jenavalve.comAgreement w/ Peijia Medical Ltd. : JenaValveJan 18, 2022

Summarized from public sources; check the original articles before acting on it.